GENDELL JEFFREY L 13D and 13G filings for Avadel Pharmaceuticals plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-06 5:55 pm Sale | 2025-12-31 | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | GENDELL JEFFREY L | 4,839,357 4.900% | -845,993 (-14.88%) | Filing |
| 2024-02-13 4:39 pm Purchase | 2023-12-31 | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | GENDELL JEFFREY L | 5,685,350 6.330% | 494,745 (+9.53%) | Filing |
| 2023-02-14 4:05 pm Purchase | 2022-12-31 | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | GENDELL JEFFREY L | 5,190,605 8.400% | 1,015,623 (+24.33%) | Filing |
| 2022-06-03 4:10 pm Purchase | 2022-05-27 | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | GENDELL JEFFREY L | 4,174,982 7.070% | 4,174,982 (New Position) | Filing |